Search Results

You searched for : Catalent

	BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
	Catalent acquires Bone Therapeutic's cell therapy manufacturing subsidiary SCTS Under the terms of the transaction, Catalent acquires Bone Therapeuticsâ€™ cell therapy manufacturing subsidiary, SCTS, for gross proceeds of â‚¬12 million... Nov 18
	Catalent launches OptiGel DR, a delayed/enteric release Softgel The drug delivery innovation major launches Softgel for Pharmaceutical and Nutraceutical Applications... Oct 24
	T-knife-Catalent sign Technology Transfer and Manufacturing Agreement for Cancer therapy Manufacturing agreement for Autologous T-Cell Receptor-Based Cell Therapy... Sep 24
	Catalent signs manufacturing agreement with AstraZeneca for COVID-19 Vaccine AZD1222 Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
	Moderna Vaccine Phase 1 trial shows it to be safe for patients Phase 1 trials establishes the safety level of Moderna's vaccine candidate... Jul 16
	Moderna and Catalent Announce Collaboration for Fill-Finish Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Modernaâ€™s COVID-19 Vaccine Candidate... Jun 26
	Catalent partners with ViralClear Pharmaceuticals ; COVID-19 treatment Catalent partners with ViralClear Pharmaceuticals on a potential treatment for COVID-19 ... Jun 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine

Catalent acquires Bone Therapeutic's cell therapy manufacturing subsidiary SCTS

Catalent launches OptiGel DR, a delayed/enteric release Softgel

T-knife-Catalent sign Technology Transfer and Manufacturing Agreement for Cancer therapy

Catalent signs manufacturing agreement with AstraZeneca for COVID-19 Vaccine AZD1222

Moderna Vaccine Phase 1 trial shows it to be safe for patients

Moderna and Catalent Announce Collaboration for Fill-Finish

Catalent partners with ViralClear Pharmaceuticals ; COVID-19 treatment

Trending Now